Zika vaccine: Investigational inactivated vaccine human trials to begin
by Press Release from Outbreak News Today on (#20RCD)
The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine candidate called the Zika Purified Inactivated Virus (ZPIV) vaccine to generate an immune system response has begun at the Walter Reed Army Institute of Research (WRAIR) Clinical Trial Center in Silver Spring, Maryland. Scientists with WRAIR, ["]
The post Zika vaccine: Investigational inactivated vaccine human trials to begin appeared first on Outbreak News Today.